Evgen Pharma PLC (AIM:EVG) flagged an article written by its chief business officer, Dr Helen Kuhlman, published today in US industry publication The Medicine Maker.
The article, The Sulforaphane Promise, focuses on the recent study of Evgen's new enteric-coated tablet formulation and why enteric coatings are of particular importance. It also discusses the pharmacodynamic and pharmacokinetic data from the recent study, demonstrating the improvements of the tablet formulation over previous formulations of SFX-01.